XLRN

Acceleron Pharma Inc.
XLRN

Overview Fund Activity
Delisted

XLRN was delisted on the 19th of November, 2021.

Back to rankings

91 hedge funds and large institutions have $709M invested in Acceleron Pharma Inc. in 2014 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 40 increasing their positions, 19 reducing their positions, and 14 closing their positions.

Holders
91
Holders Change
+12
Holders Change %
+15.19%
% of All Funds
2.62%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
27
Increased
40
Reduced
19
Closed
14
Calls
$3.36M
Puts
$296K
Net Calls
+$3.07M
Net Calls Change
+$3.07M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$160M
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$111M
3
QF
3
QVT Financial
New York
$39.2M
4
SAM
4
Sectoral Asset Management
Quebec, Canada
$20M
5
State Street
5
State Street
Massachusetts
$18.8M

Top Sellers

1
O
1
OrbiMed
New York
$5.84M
2
DVC
2
Deer VII & Co
New York
$5.95M
3
PVMCI
3
Polaris Venture Management Co IV
Massachusetts
$95.2M
4
ICAP
4
Independence Capital Asset Partners
Colorado
$527K
5
AQR Capital Management
5
AQR Capital Management
Connecticut
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$160M 4,718,364 +2,115,587 +81%
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$111M 3,271,727 +1,427,884 +77%
PVMCI
3
Polaris Venture Management Co IV
Massachusetts
$95.2M 2,803,645 -513,491 -15%
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$51.7M 1,520,666 +178,469 +13%
QF
5
QVT Financial
New York
$39.2M 1,154,058 +597,484 +107%
Vanguard Group
6
Vanguard Group
Pennsylvania
$23.3M 686,528 +299,820 +78%
Franklin Resources
7
Franklin Resources
California
$22.3M 657,377 -71,200 -10%
SAM
8
Sectoral Asset Management
Quebec, Canada
$20M 589,053 +589,053 New
State Street
9
State Street
Massachusetts
$18.8M 552,445 +444,966 +414%
JPMorgan Chase & Co
10
JPMorgan Chase & Co
New York
$16.2M 478,306 -27,648 -5%
Loomis, Sayles & Company
11
Loomis, Sayles & Company
Massachusetts
$14M 411,781 +123,407 +43%
BFA
12
BlackRock Fund Advisors
California
$12.3M 362,428 +162,329 +81%
PA
13
Perceptive Advisors
New York
$10.2M 300,000 +300,000 New
Invesco
14
Invesco
Georgia
$9.61M 283,027 +41,527 +17%
BA
15
BlackRock Advisors
Delaware
$8.04M 236,743 +7,824 +3%
CAM
16
Cormorant Asset Management
Massachusetts
$6.79M 200,000 +200,000 New
BIT
17
BlackRock Institutional Trust
California
$6.19M 182,121 +101,121 +125%
DVC
18
Deer VII & Co
New York
$5.95M 175,075 -930,889 -84%
O
19
OrbiMed
New York
$5.84M 171,800 -1,696,000 -91%
DCM
20
Driehaus Capital Management
Illinois
$5.58M 164,282 +40,281 +32%
UBS AM
21
UBS AM
Illinois
$4.1M 120,800 +56,200 +87%
Lord, Abbett & Co
22
Lord, Abbett & Co
New Jersey
$4.1M 120,683 +10,318 +9%
IHM
23
Iguana Healthcare Management
New York
$3.74M 110,000 +110,000 New
Northern Trust
24
Northern Trust
Illinois
$3.43M 100,961 +14,346 +17%
WSA
25
Wall Street Associates
California
$3.16M 93,100 +300 +0.3%
1
2 3 4 5